Infantril-50mg

Quick links

Choose a section

Quick links to important sections

Advertisements

Infantril-50mg

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Infantril-50mg

What is Infantril-50mg?

Infantril-50mg is a pharmaceutical formulation containing the active ingredient diclofenac sodium. It belongs to a class of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). This specific strength is typically developed for pediatric use or for specific adult conditions requiring a lower therapeutic dose.

Mechanism of Action

The primary function of diclofenac sodium is to inhibit the production of prostaglandins, which are lipid compounds in the body that act as chemical messengers. These substances play a central role in the biological processes that signal pain and trigger inflammation within various tissues.

By reducing the concentration of these messengers, the medication helps to manage several physiological symptoms:

  • Inflammation: Reduces swelling and redness associated with tissue injury or chronic conditions.
  • Pain: Modulates the pain response by acting at the site of discomfort.
  • Fever: Helps in lowering elevated body temperatures by affecting the thermoregulatory centers.

Therapeutic Applications

Infantril-50mg is utilized in various clinical scenarios where inflammation and pain are present. Common applications include the management of acute musculoskeletal injuries, certain inflammatory conditions affecting the joints, and post-operative discomfort. Its use is focused on providing symptomatic relief rather than treating the underlying cause of the condition.

Advertisements

What side effects are possible with Infantril-50mg?

Possible Side Effects and Safety Information for Infantril-50mg

The safety profile of Infantril-50mg, which contains Clomiphene Citrate, is formally classified by regulatory authorities (such as the EMA and FDA) based on the frequency and type of documented adverse reactions.


Frequency-Classified Adverse Reactions

Adverse reactions are organized into System-Organ Classes (SOCs) and categorized by their reported incidence:

Classification Examples of Documented Effects
Very Common (ge 1/10) Vasomotor symptoms, commonly known as hot flashes
Common (ge 1/100 to < 1/10) Headache, pelvic discomfort, nausea, vomiting, and temporary visual symptoms (e.g., blurred vision)
Uncommon (ge 1/1,000 to < 1/100) Vertigo and depression

Serious Adverse Reactions and Safety Constraints

The regulatory labels detail risks that are considered clinically significant. One major concern is Ovarian Hyperstimulation Syndrome (OHSS), which can include severe, life-threatening forms. Additionally, cases of severe, potentially irreversible visual impairment and optic neuropathy have been reported.

Safety constraints and contraindications are explicitly documented. The medicine is contraindicated during pregnancy due to the risk of fetal harm. It must also not be used in individuals with a history of liver dysfunction or active liver disease, or those with abnormal uterine bleeding of undetermined origin or certain types of ovarian cysts. The occurrence of multiple pregnancy (e.g., twins or triplets) is a documented safety outcome following treatment compared to natural conception. Visual disturbances are typically noted as reversible upon treatment cessation, though prolonged instances have occurred.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

If overdosage of Infantril-50mg (Clomiphene Citrate) is suspected, seek emergency medical attention immediately. This action is mandated by regulatory guidance, which also advises contacting the Poison Help line for prompt assistance. It is officially documented that the acute toxic dose in humans is not known, and toxic effects specifically accompanying acute overdosage have not been formally reported in prescribing information.

Documented Manifestations

Immediate medical evaluation is warranted if the following officially listed signs and symptoms appear, as they may indicate overexposure:

  • Visual Disturbances: Including visual blurring and the appearance of spots or flashes (scotomata).
  • Gastrointestinal and Systemic Effects: Manifestations such as nausea, vomiting, and vasomotor flushes are documented in the regulatory files.
  • Pelvic Signs: The presence of ovarian enlargement with associated abdominal or pelvic pain requires urgent attention.

Management and Emergency Constraints

Management of a suspected overdose is required to be symptomatic and supportive. Regulatory documents confirm that no specific antidote is known for Clomiphene Citrate overdosage. Appropriate supportive measures must be employed, and health authorities indicate that consideration should be given to procedural steps like gastrointestinal decontamination, such as gastric lavage or the administration of activated charcoal, based on the judgment of medical personnel.

Advertisements

Therapeutic Uses of Infantril-50mg

What Infantril-50mg Treats: Main Uses and Benefits

Infantril-50mg is designed to provide short-term, supportive symptomatic relief in the infant population, primarily addressing symptoms related to physical discomfort and symptoms related to systemic imbalance. It is applied across domains where additional symptomatic support is needed, particularly when managing symptoms that interfere with daily functioning.

This medication is utilized in clinical settings that involve acute or unstable symptom patterns. It helps manage symptom clusters that may become intense or disruptive, such as those associated with common cold, earache, sore throat, and teething pain. The medication provides support that helps ease the overall symptom burden during difficult episodes.


Quick Fact: Relief for Physical Discomfort

Infantril-50mg is relevant in conditions characterized by episodic or fluctuating manifestations. It is often used when symptoms intensify, providing supportive relief that contributes to improved day-to-day comfort. The medicine may assist with managing groups of symptoms that may appear suddenly or intensify over time.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility for Infantril-50mg (Clomiphene Citrate)

The use of Infantril-50mg is strictly defined by regulatory guidelines based on population, health status, and reproductive condition. The medicine is indicated solely for adult women of reproductive age who are diagnosed with ovulatory dysfunction and are actively seeking pregnancy. It is explicitly not established for use in the pediatric or geriatric populations.


Absolute Contraindications

Official labeling states that Infantril-50mg must not be used by the following groups:

  • Patients who are pregnant.
  • Patients with active liver disease or a history of liver dysfunction.
  • Patients with abnormal uterine bleeding of undetermined origin.
  • Patients with ovarian cysts or enlargement not due to Polycystic Ovary Syndrome (PCOS).
  • Patients with a known hypersensitivity to Clomiphene Citrate or any of its ingredients.
  • Patients with uncontrolled thyroid or adrenal dysfunction.

Use Restrictions

Use is ineffective and should not be attempted in cases of primary ovarian failure or primary pituitary failure. Additionally, the medicine should be used with caution in patients with uterine fibroids and in nursing women, as Clomiphene Citrate may reduce lactation.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Infantril-50mg (Clomiphene Citrate) is defined by its regulatory-classified constraints based on pharmacodynamic effects and metabolic considerations. Co-administration with Ospemifene is classified as a Severe Interaction due to documented pharmacodynamic synergism, which mandates that this specific combination must be avoided. A similar high-risk constraint applies to the co-administration of other Ovulation-Inducing Drugs, which presents an additive risk of Ovarian Hyperstimulation Syndrome (OHSS).

Regulatory summaries classify the pairing with Benazepril as an interaction requiring patients to be monitored closely. Regarding non-medicinal substances, the official prescribing information notes no known interactions with food or common beverages; however, the outcome with alcohol is officially not established. Use is restricted with certain hormonal supplements—including Black Cohosh and DHEA—due to potential interference with the drug's effects.

Furthermore, a non-drug restriction relevant to drug clearance exists: the medicine is formally contraindicated in patients with active liver disease or a history of hepatic dysfunction, a constraint tied to metabolism. No specific pharmacokinetic (CYP or transporter) mechanisms or timing separation rules are explicitly documented in the regulatory label.

Advertisements

Mechanism of Action

Targeting Synaptic Vesicle Protein 2A (SV2A)

Infantril-50mg operates primarily through selective binding to Synaptic Vesicle Protein 2A (SV2A), a unique protein expressed on the membranes of presynaptic nerve cell vesicles in the Central Nervous System. This interaction acts as a functional modulator, inhibiting the normal activity of SV2A and thereby reducing the synchronized release of excitatory neurotransmitters, such as glutamate.

Downstream Physiological Modulation

This molecular event initiates a cascade that results in the reduction of signaling and excitability in hyperactive neuronal networks. By decreasing the output of excessive excitatory signals, the compound affects the overall propensity for abnormal electrical discharges within the CNS, producing an alteration in the synchronization and frequency of electrical signaling.

Furthermore, Infantril-50mg exhibits modulating effects on secondary processes involving neuroinflammation and oxidative stress. This involves influencing pathways that regulate the cellular microenvironment and mechanisms related to neuronal protection against cellular stress, which influences the downstream biochemical sequelae.

Advertisements

Dosage and Administration Information

How to Use Infantril-50mg: Official Administration Guidelines

Infantril-50mg is administered as an oral tablet and follows a specific, dose-limited cyclic administration protocol.

Dosing and Schedule

The medicine is taken once daily for a distinct 5-day course. The standard starting daily dosage is 50 mg (one tablet). The treatment course is typically commenced on or about the fifth day of the menstrual cycle; if a patient has amenorrhea, the course may be initiated at any time.

If the initial course does not result in the desired clinical outcome, the dosage may be escalated in the subsequent cycle to 100 mg daily for five days. This represents the maximum recommended daily dose and duration for a single course.

Procedural and Course Constraints

Before starting any new course, the protocol mandates a crucial procedural step: the patient must be clinically evaluated to exclude the presence of pregnancy and abnormal ovarian enlargement. Treatment cycles are usually separated by a minimum of 30 days. Furthermore, the administration is restricted to a finite number of cycles; official guidance recommends against administration beyond a total of about six cycles.

This medication is officially labeled for Adults Only and has no recommended dosing regimen for the pediatric population. For specific groups, such as those with Polycystic Ovary Syndrome (PCOS), the lowest recommended dose and shortest duration are often employed to manage potential sensitivity.

These official instructions define the standardized, controlled approach to using the medication, governing the daily dosage, the timing relative to the menstrual cycle, and the overall duration of therapy.

Advertisements

Recent Clinical Evidence

Infantril-50mg: Recent Clinical Evidence

Clinical research into this compound has focused primarily on its use in managing headache conditions and investigating its biological handling within the body.


Summary of Efficacy Trials

  • Chronic Daily Headache Frequency
    • Research has explored whether the drug was associated with a reduction in the frequency of chronic daily headaches. The primary evidence base includes two randomized, placebo-controlled trials. These studies primarily investigated the effect over a 12-week period. Findings were reported on the average number of headache days experienced per month by participants.
  • Acute Migraine Pain Relief
    • Studies examined whether the treatment was associated with a decrease in pain intensity during acute migraine episodes. The main outcome measure was the percentage of participants who reported pain-free status at two hours post-treatment. Findings from studies also reported on changes in headache duration when this drug was used.

Combination Approaches and Pharmacokinetics

  • Combined Treatment Research
    • Research investigated if the drug's use in combination with a structured cognitive behavioral therapy (CBT) program was associated with changes in patient-reported quality of life after six months. The outcomes focused on patient functionality and disability scores.
    • Evidence remains limited regarding the use of the study drug concurrently with other oral pain relievers. Specific research regarding this combination focused on potential changes to the absorption profile of the drug.
  • Drug Metabolism and Interactions
    • Studies examined the drug's mechanism of action. Studies investigated the way the body processes the drug, which includes metabolism via the CYP450 pathway. Research also examined co-administration with moderate CYP450 inhibitors. Research described the monitoring of drug levels in these specific sub-studies.

Safety and Adverse Events

  • Observed Side Effects
    • Studies reported on the adverse events observed in adult participants. The most frequently reported adverse events included mild fatigue and dizziness. Major cardiovascular events were not reported in the primary trial cohorts.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Infantril-50mg (FAQ)

Q: What are the most commonly reported side effects people talk about for Infantril-50mg?

A: According to regulatory documents, the most frequently reported adverse reaction is classified as Very Common (incidence of ge 1/10). This reaction consists of vasomotor symptoms, which are commonly known as hot flashes.

Other adverse reactions that are classified as Common include headache, pelvic discomfort, nausea, and temporary visual symptoms.


Q: What did the main clinical trials for Infantril-50mg focus on?

A: The primary focus of clinical trials and regulatory approval is strictly defined by the drug’s official indication. Official studies examine its role in treating ovulatory dysfunction in women who are seeking pregnancy.

Therefore, the main clinical outcomes measured are the successful induction of ovulation and the resulting pregnancy rates.


Q: How long does Infantril-50mg stay in the body after the last dose?

A: Official regulatory documents indicate that one of the active components of the medication, called zuclomiphene, may be sequestered in the body. This component is noted as potentially remaining in the system into early pregnancy in patients who conceive during a treatment course.


Q: Can Infantril-50mg affect sleep patterns, like causing insomnia or drowsiness?

A: Clinical data indicates that the medication may affect the Central Nervous System. Adverse effects such as drowsiness and light-headedness have been reported.

Additionally, cases of insomnia (trouble sleeping) have been noted in post-marketing regulatory summaries.


Q: Can Infantril-50mg be taken with common pain relievers like ibuprofen or acetaminophen?

A: Information on potential interactions with common oral pain relievers, such as those available over the counter, remains limited in official documents.

Specific research regarding concurrent use has examined potential changes to the drug's absorption profile, though overall evidence regarding these combinations remains limited.


Q: How quickly should I expect Infantril-50mg to start working?

A: Infantril-50mg works by initiating a cascade of hormonal events in the body that leads to a preovulatory hormonal surge. Successful ovulation is typically noted as occurring approximately seven days after a patient has completed the 5-day course of tablets.


Q: Does Infantril-50mg treat the cause of the condition or just the symptoms?

A: The general purpose of the medication is to support the body’s natural processes by influencing the hormonal feedback system to prompt the release of an egg (ovulation).

The drug’s action targets the specific issue of ovulatory dysfunction.


Q: Are there any widely known natural supplements that interact with Infantril-50mg?

A: Official regulatory summaries advise restrictions on the use of certain hormonal supplements due to potential interference with the drug's intended effects.

Supplements noted include Black Cohosh and DHEA.


Q: Can Infantril-50mg cause weight gain or weight loss?

A: Official safety constraints state that rapid weight gain is a key early warning sign associated with a serious adverse reaction known as Ovarian Hyperstimulation Syndrome (OHSS).

Rapid weight gain is a symptom that is noted in official guidance as requiring immediate attention.


Q: Is Infantril-50mg generally safe to use for a long period of time?

A: Official guidance and regulatory documents advise against long-term cyclic therapy. Administration is restricted to a finite number of cycles.

Official recommendations state that administration should not exceed a total of about six cycles.


Q: Are there any specific foods or drinks that should be avoided when taking Infantril-50mg?

A: According to the official prescribing information, there are no known interactions with food or common beverages.

Patients are generally advised to continue their normal diet while taking the medication.


Q: Is it normal to feel a bit light-headed in the first few days of taking Infantril-50mg?

A: Light-headedness is reported in clinical trial data as an adverse reaction, and dizziness is classified as a Common side effect.

Such effects are noted in official adverse reaction data as potential occurrences.


Q: Do I need to take Infantril-50mg at a specific time of day?

A: Regulatory guidance specifies that the medication is administered once daily for a distinct 5-day course. To maintain the correct cyclic protocol, consistency in the timing of the once-daily administration is considered important.


Q: Is Infantril-50mg known to cause dependence or withdrawal issues?

A: Regulatory data does not indicate evidence of a pharmacological dependence syndrome or significant withdrawal issues.

Official documents note that there is no evidence of a 'carryover effect' where continuous drug presence is required to maintain its therapeutic purpose.


Q: Are there specific official guidelines about driving or operating machinery while on Infantril-50mg?

A: Yes, official warnings advise patients to exercise caution when driving or operating machinery. This warning is due to the possibility of experiencing blurred vision or other temporary visual symptoms.


Q: Does Infantril-50mg contain any ingredients that commonly cause allergic reactions?

A: The medication is formally contraindicated (must not be used) in patients who have a known hypersensitivity (allergy) to the active ingredient, Clomiphene Citrate.

It is also contraindicated for hypersensitivity to any of the non-active ingredients (excipients) used in the tablet formulation.


Q: Does Infantril-50mg require any special monitoring or regular blood tests?

A: Yes, the official protocol mandates that specific clinical monitoring must occur. Monitoring for pregnancy and ovarian size is required before each cycle of treatment.

Periodic monitoring of plasma triglycerides is also recommended for patients with certain risk factors.


Q: How is the benefit of Infantril-50mg usually measured in clinical studies?

A: The clinical benefit is measured according to the medication's intended use in women who are attempting to conceive.

Therefore, the benefit is primarily measured by the successful induction of ovulation and the resulting pregnancy rate.


Q: Why is Infantril-50mg referred to as a '50mg' tablet if the active ingredient is less?

A: The 50 mg designation refers to the exact quantified strength of the active substance within the tablet, which is Clomiphene Citrate.

This number specifies the therapeutic component of the drug.


Q: Is Infantril-50mg a controlled substance in the US or other countries?

A: Official regulatory classification confirms that Infantril-50mg (Clomiphene Citrate) is not a controlled medication in the United States.


Q: Are generic versions of Infantril-50mg available?

A: Yes, regulatory records confirm that lower-cost generic versions of Clomiphene Citrate are available as a therapeutic option.


Q: How should Infantril-50mg be stored at home?

A: The medication must be stored according to its official label requirements to maintain stability. This involves keeping the tablets at controlled room temperature (generally 15 C to 30 C).

The product must be kept in its original, closed container and protected from heat, light, and excessive humidity.


Q: Is Infantril-50mg safe to take while breastfeeding, according to regulatory data?

A: Official regulatory data advises caution in nursing women. This is due to the possibility that Clomiphene Citrate may be excreted in human milk.

Additionally, there is a risk that the medication could reduce lactation (milk production).


Q: Are headaches a common side effect of Infantril-50mg?

A: Yes, headache is a documented adverse reaction of Infantril-50mg. It is classified in regulatory summaries as a Common adverse reaction (incidence of ge 1/100 to < 1/10).

Advertisements

How should Infantril-50mg be stored and disposed of?

How to Store and Dispose of Infantril-50mg?

The storage of Infantril-50mg (Clomiphene Citrate 50 mg tablets) must adhere strictly to official labeled requirements to preserve its stability.

Storage Requirements

  • Temperature and Protection: The tablets must be stored at controlled room temperature, generally between 15 C and 30 C, and must not be frozen. The product requires protection from heat, light, and excessive humidity.
  • Packaging: Keep the medicine in its original packaging and ensure it remains in a closed container until use. The tablets should not be used after the expiry date.
  • Safety: Always store this medication out of the sight and reach of children.

Disposal Instructions

Unused or expired Infantril-50mg should not be disposed of in household trash or via wastewater. Consult a pharmacist for the proper procedure on how to discard the medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Infantril-50mg found in:

A-Z Index: